Media Hub

Innate Killer - Beacon Infographic

Data Analysis: Assets by Therapeutic Class and Status & Developers with the Highest Number of Assets

Source:
Beacon Cell Therapy 6th December 2023

exclusive interview

Exclusive Interview - Innate Killer Summit 2022

Neil Sheppard
Adjunct Associate Professor of Pathology &
Laboratory Medicine

University of Pennsylvania

Michael Curley
Director Cell Therapy Innovation
Takeda

Allen Feng
CEO
HebeCell Corp

Gregory Fiore
CEO
Exacis Biotherapeutics

Speaker Perspectives - Innate Killer

Speaker Perspectives - Innate Killer Summit 2022

Austin Bigley
VP R&D
Indapta Therapeutics

Kimberly Schluns
Senior Director Research
Kite: A Gilead Company

Podcast - Innate Killer Summit 2023

Neil Sheppard
University of Pennsylvania
Center for Cellular Immunotherapies